Hi,
I contacted the company and they would only advise that France final approval will occur in the first half of 2016. Further to this, submissions for other countries have not been filed.
The production capacity of MVP is limited to about 200K units per month until Somersby production facility is commissioned in July/August. So maybe they could not reliably service demand in France until that facility is complete.
I am anticipating growth in the order of 20% for six months and full financial year. Basis is growth of Penthrox sales and growth in respiratory division.
DYOR.
Hi, I contacted the company and they would only advise that...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
-0.010(2.06%) |
Mkt cap ! $41.85M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.5¢ | 47.5¢ | $2.597K | 5.452K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4630 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 2489 | 5 |
View Market Depth
| Last trade - 13.17pm 25/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |